Application

14939513 · Intermediates for producing NEP inhibitors or prodrugs thereof

Filed 2015-11-12 · Granted · Patent 9403766 (2016-08-02) The official file ↗The patent and its PDF ↗ · Art unit 1626 · Examiner Matthew P Coughlin Typical · CPC C07D 207/38 · NOVARTIS PHARMACEUTICAL CORPORATION

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

1.0 mo

to disposition 8.7 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.